News search

E.g., 24/11/2024
E.g., 24/11/2024
Vicente Andrés, director de investigación básica del CNIC; Dr. Valentín Fuster, director general del CNIC; Dra. del Instituto de Salud Carlos III, Dra. Marina Pollán; Alberto Sanz, director gerente del CNIC; el Dr. Borja Ibáñez, director científico y director de investigación clínica del CNIC; D. Agustín González, subdirector general de redes y centros de investigación cooperativa del Instituto de Salud Carlos III., e Icíar Areilza, secretaria general de la Fundación Pro CNIC.
María Linarejos Vera, Gema Mondéjar, Amaia Talavera, Patricia Sánchez, Álvaro Macías, Juan Manuel Ruiz, Francisco M. Cruz, Fernando Martínez de Benito, Juan Antonio Bernal y José Jalife
Research
11 Apr 2024

CNIC researchers, led by Dr. José Jalife, have made a key discovery about cardiac arrhythmias in Andersen-Tawil syndrome (ATS)

El Dr. Valentín Fuster con la Dra. Guiomar Mendieta
About the CNIC
10 Apr 2024

Guiomar Mendieta has been awarded the 2023 William W. Parmley Young Author Achievement Award for a paper published in JACC that is considered to an outstanding contribution in the field of atherosclerosis

 Rodrigo Fernández Jiménez ha sido galardonado con el Premio Nacional de Investigación para Jóvenes ‘Gabriella Morreale’
About the CNIC
15 Mar 2024

The award honours the quality and relevance of his research work in preventive medicine and on current challenges in the field of cardiology


About the CNIC
9 Feb 2024

The National Center for Cardiovascular Research Carlos III (CNIC) is excited to announce the upcoming edition of the CNIC Conferences

Carlos Torroja, Jacob F. Bentzon, Paula Nogales, Laura Carramolino, Vanessa Cumbicus, Daniel Morales, Ana Dopazo, Verónica Labrador y Alberto Benguria
Research
1 Feb 2024

A study published in Nature Cardiovascular Research reveals smooth muscle-derived cells as a new target for reducing the size of atherosclerotic plaque. The results open up new avenues for the design of treatments to enhance the beneficial effect of cholesterol-lowering drugs


Catarina Tristão Pereira, Enrique Lara Pezzi, Raquel Toribio Fernández, Borja Ibáñez, Valentín Fuster, Sergio Callejas, Marta Cortés Canteli, Ana Dopazo, Pilar Martín, Inés García Lunar e Irene Fernández Nueda.
Research
23 Jan 2024

The most potent genetic risk factor for Alzheimer disease, APOE4, is associated with an elevated risk of developing subclinical atherosclerosis in middle age, whereas the Alzheimer-protective variant of the same gene, APOE2, protects against subclinical atherosclerosis

Ayelén M. Santamans y Guadalupe Sabio
Research
19 Jan 2024

A team led by scientists from the CNIC and CNIO has identified a potential therapeutic target that protects the heart in patients with pulmonary hypertension

Research
3 Jan 2024

A team led by scientists at the CNIC and CSIC has found that accumulation of versican in the aortas of Marfan syndrome patients triggers the activation of the nitric oxide pathway through the activation of the the protein AKT